Hsbc Holdings PLC Cidara Therapeutics, Inc. Transaction History

Hsbc Holdings PLC

  • $168 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
SELL
$0.45 - $13.0 $8,216 - $237,354
-18,258 Reduced 51.78%
17,001 $11,000
Q2 2022

Aug 11, 2022
SELL
$0.43 - $0.91 $2,094 - $4,433
-4,872 Reduced 12.14%
35,259 $17,000
Q2 2021

Aug 13, 2021
BUY
$1.87 - $2.7 $23,260 - $33,585
12,439 Added 44.92%
40,131 $81,000
Q1 2021

May 14, 2021
BUY
$2.06 - $3.01 $57,045 - $83,352
27,692 New
27,692 $73,000

About Cidara Therapeutics, Inc.

CDTX Quotes by TradingView
  • Ticker CDTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,075,696
  • Market Cap $1.63B
  • Description
  • Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifu...
More about CDTX
Track This Portfolio

Track Hsbc Holdings PLC Portfolio

Follow Hsbc Holdings PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email